Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)
Favipiravir has demonstrated in this study an indirect role in reducing household SARS-CoV-2 transmission, showing notable efficacy in symptomatic and unvaccinated index cases. This breakthrough highlights its potential in broader public health strategies. Exploring the roles and challenges of other anti-SARS-CoV-2 agents remains a vital goal in ongoing research.
Authors
- Marisa Muadchimkaew (ORCID: https://orcid.org/0000-0003-1753-7157)
- Pureepat Arttawejkul
- Kriangkrai Tawinprai (ORCID: https://orcid.org/0000-0002-2862-948X)
- Nithi Mahanonda (ORCID: https://orcid.org/0000-0003-4473-4121)
- Taweegrit Siripongboonsitti (ORCID: https://orcid.org/0000-0001-7256-9982)
- Kamonwan Soonklang (ORCID: https://orcid.org/0000-0002-8053-2984)
- Ornisa Issaranon
- Wichuda Meepholkij
- Apiradee Vararungzarit
- Onwalee Dhissayakamol
- Wilaiporn Preeyachit
Institutions
- Burapha University (TH)
- Chulabhorn Hospital (TH)
- Rajamangala University of Technology Suvarnabhumi (TH)
Publication Details
- Journal
- Journal of Virus Eradication
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.jve.2024.100576
- Primary Topic
- COVID-19 epidemiological studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chulabhorn Royal Academy